cyclosporine a plus low-dose steroid treatment in covid-19 reduces clinical outcomes in patients with moderate to severe disease.
cyclosporine a plus low-dose steroid treatment in covid-19 reduces clinical outcomes in patients with moderate to severe disease.
conclusion: csa used as an adjuvant to steroid treatment for covid-19 patients showed to improve outcomes and reduce mortality, mainly in those with moderate to severe disease.